Compare Ganges Securitie with Similar Stocks
Total Returns (Price + Dividend) 
Ganges Securitie for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ganges Securities Ltd Valuation Shifts to Fair Amidst Weak Market Performance
Ganges Securities Ltd, a micro-cap player in the FMCG sector, has seen a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this adjustment, the company continues to face significant headwinds, reflected in its recent share price decline and a strong sell rating from MarketsMOJO. This article analyses the valuation changes, compares them with peers, and examines the implications for investors.
Read full news article
Ganges Securities Ltd is Rated Strong Sell
Ganges Securities Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Ganges Securities Ltd Valuation Shifts Signal Heightened Price Risk Amid Mixed Returns
Ganges Securities Ltd, a micro-cap player in the FMCG sector, has seen its valuation parameters deteriorate sharply, with its price-to-earnings (P/E) ratio escalating to 43.58, marking a shift from expensive to very expensive territory. This re-rating, coupled with a strong sell Mojo Grade of 21.0, underscores growing concerns about the stock’s price attractiveness relative to its historical and peer benchmarks.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
26-Aug-2026 | Source : BSECopy of newspaper publication
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Aug-2026 | Source : BSECopy of newspaper publication
Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2026
13-Aug-2026 | Source : BSEOutcome of Board Meeting held on August 13 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 1 FIIs (0.03%)
Sil Investments Limited (13.38%)
Navjeewan Medical Institute (6.21%)
21.46%
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 21.07% vs -17.62% in Jun 2025
YoY Growth in quarter ended Jun 2026 is 18.45% vs -1.90% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -4.41% vs 19.10% in Sep 2024
Growth in half year ended Sep 2025 is -52.87% vs 35.93% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.98% vs 11.81% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -41.05% vs 22.30% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -4.92% vs 9.08% in Mar 2025
YoY Growth in year ended Mar 2026 is -46.84% vs 45.40% in Mar 2025






